Post-Exposure Prophylaxis for COVID-19: A Systematic Review.
SeyedAlinaghi S, Karimi A, Pashaei Z, Shobeiri P, Janfaza N, Behnezhad F, Ghasemzadeh A, Barzegary A, Arjmand G, Noroozi A, Shojaei A, Amiri A, Vahedi F, Mahalleh M, Shamsabadi A, Dashti M, Afsahi AM, Mehraeen E, Dadras O.
SeyedAlinaghi S, et al.
Infect Disord Drug Targets. 2023;23(5):e130423215723. doi: 10.2174/1871526523666230413082721.
Infect Disord Drug Targets. 2023.
PMID: 37069717
Chloroquine was recommended to use to control treatment in patients with mild to severe COVID-19 pneumonia. Other agents like Lopinavir-ritonavir (LPV/r), angiotensinconverting enzyme inhibitors (ACEIs), Angiotensin receptor blockers (ARBs), Vitamin D, arbidol, thymosin dr …
Chloroquine was recommended to use to control treatment in patients with mild to severe COVID-19 pneumonia. Other agents like Lopinavir-rito …